Digoxin toxicity: clinical and laboratory assessment

Area of Science:

• Pharmacology
• Clinical Medicine
• Toxicology

Background:

• Digoxin is a critical medication for heart conditions, but its narrow therapeutic index necessitates careful monitoring.
• Clinical signs of digoxin toxicity can be ambiguous, making accurate diagnosis challenging.

Purpose of the Study:

• To investigate the correlation between clinical digoxin toxicity and measured serum digoxin levels.
• To determine the utility of serum digoxin levels as a sole diagnostic marker for toxicity.

Main Methods:

• A prospective study involving 67 patients, categorizing them into clinically toxic (n=24) and asymptomatic (n=43) groups.
• Serum digoxin levels were measured using radioimmunoassay at least six hours post-dose.
• Clinical toxicity was determined by characteristic cardiac arrhythmias or non-cardiac symptoms.

Main Results:

• The mean serum digoxin level was significantly higher in the toxic group (2.09 +/- 1.28 ng/ml) compared to the non-toxic group (1.20 +/- 0.75 ng/ml) (p < 0.01).
• All non-toxic patients had levels below 3 ng/ml.
• A significant overlap in serum digoxin levels was observed between toxic and non-toxic patients.

Conclusions:

• Serum digoxin levels alone are insufficient for diagnosing digoxin toxicity.
• Elevated serum digoxin levels, especially exceeding 3 ng/ml, in conjunction with suggestive clinical features, strongly indicate toxicity.
• Integrated assessment of clinical presentation and serum levels is crucial for accurate digoxin toxicity diagnosis.